Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA petitions

This article was originally published in The Tan Sheet

Executive Summary

OTC and supplement labels' use of the phrases "may contain," "may also contain" or "and/or" to list inactive and non-supplement ingredients is requested in two petitions submitted to FDA Sept. 8. CHPA's requests echo a petition submitted by Arnall Golden & Gregory June 2 (1"The Tan Sheet" June 5, p. 4). OTC drug and supplement labeling regs require all companies to list inactives on packaging, but the "specific makeup of composite inactive ingredients can vary slightly from supplier to supplier," CHPA notes, and multiple suppliers are necessary to ensure uninterrupted flow of products. Alerting consumers to potential allergens, a possible advantage to the requirements, is unjustified since consumers can self-select to their needs among the many competing products on the market, the association contends
Advertisement

Related Content

OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
OTC Inactive Ingredient Labeling Guidance To Be Issued By FDA
Inactive Ingredient "May Contain" Listing Sought By Perrigo
Inactive Ingredient "May Contain" Listing Sought By Perrigo
Inactive Ingredient "May Contain" Listing Sought By Perrigo
Dietary Supplement Ingredient Alphabetical Listing Sought In Citizen Petition
Dietary Supplement Ingredient Alphabetical Listing Sought In Citizen Petition
Varying Inactive Ingredient Listing On OTC Labeling Requested
Varying Inactive Ingredient Listing On OTC Labeling Requested

Topics

Advertisement
UsernamePublicRestriction

Register

PS091654

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel